Bill Sullivan

With more than 25 years of experience in corporate finance, strategic transactions, fundraising, and investor relations, Bill Sullivan joined Life Biosciences as chief financial officer. He was previously chief financial officer and treasurer at Applied Genetic Technologies Corporation (AGTC), a publicly traded gene therapy company, where he led multiple financings and core business and finance functions. Prior to AGTC, he worked at Merrimack Pharmaceuticals, Inc. for 10 years and held a variety of important leadership positions including chief financial officer. At Merrimack, he led the company’s $100 million initial public offering, helped the company raise over $400 million in debt and equity capital as a public company, and played a key role in Merrimack’s asset sale to Ipsen SA for up to $1.025 billion. Prior to his role at Merrimack, Bill worked for a number of years in the high-technology sector. He holds a BA in economics from Williams College and an MBA and MS in accounting from Northeastern University and obtained his certified public accountant license while working at Arthur Andersen, LLP.